These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32986099)
61. Inclusion of children and pregnant women in COVID-19 intervention trials. Malhotra A; Kumar A; Roehr CC; den Boer MC Pediatr Res; 2021 Apr; 89(5):1063-1064. PubMed ID: 32688370 [No Abstract] [Full Text] [Related]
66. The 'new normality' in research? What message are we conveying our medical students? Catalán V; Rodríguez A; Becerril S; Unamuno X; Mentxaka A; Gómez-Ambrosi J; Frühbeck G Eur J Clin Invest; 2021 Sep; 51(9):e13586. PubMed ID: 33932225 [No Abstract] [Full Text] [Related]
67. Moving forward in clinical research with master protocols. Park JJH; Dron L; Mills EJ Contemp Clin Trials; 2021 Jul; 106():106438. PubMed ID: 34000408 [TBL] [Abstract][Full Text] [Related]
68. Methodology over metrics: current scientific standards are a disservice to patients and society. Van Calster B; Wynants L; Riley RD; van Smeden M; Collins GS J Clin Epidemiol; 2021 Oct; 138():219-226. PubMed ID: 34077797 [TBL] [Abstract][Full Text] [Related]
69. Sex and gender missing in COVID-19 data. O'Grady C Science; 2021 Jul; 373(6551):145. PubMed ID: 34244389 [No Abstract] [Full Text] [Related]
71. Practical tips for surgical research: how to optimize patient recruitment. Thoma A; Farrokhyar F; McKnight L; Bhandari M Can J Surg; 2010 Jun; 53(3):205-10. PubMed ID: 20507795 [No Abstract] [Full Text] [Related]
72. Can understanding mechanisms solve the problem of extrapolating from study to target populations (the problem of 'external validity')? Howick J; Glasziou P; Aronson JK J R Soc Med; 2013 Mar; 106(3):81-6. PubMed ID: 23481429 [No Abstract] [Full Text] [Related]
73. Prevalence and proportion by age and sex of chronic health conditions in a large healthcare system. Gronich N; Saliba W; Schwartz JB PLoS One; 2024; 19(9):e0308031. PubMed ID: 39325771 [TBL] [Abstract][Full Text] [Related]
74. Challenges and Solutions in Recruiting Older Vulnerable Adults in Research. Sourial N; Beuscart JB; Posłuszny Ł; Calafiore M; Sousa SS; Sansone E; Zuber M; Vedel I; Int J Public Health; 2024; 69():1607247. PubMed ID: 39140076 [No Abstract] [Full Text] [Related]
75. Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England. Pessoa-Amorim G; Goldacre R; Crichton C; Stevens W; Nunn M; King A; Murray D; Welsh R; Pinches H; Rees A; Morris EJA; Landray MJ; Haynes R; Horby P; Wallendszus K; Peto L; Campbell M; Harper C; Mafham M Trials; 2024 Jun; 25(1):429. PubMed ID: 38951929 [TBL] [Abstract][Full Text] [Related]
76. Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Chronic Pain. Boyd T; Chibueze J; Pester BD; Saini R; Bar N; Edwards RR; Adams MCB; Silver JK; Meints SM; Burton-Murray H J Pain; 2024 Aug; 25(8):104511. PubMed ID: 38492711 [TBL] [Abstract][Full Text] [Related]
77. Exploring the prevalence of anabolic steroid use among men and women resistance training practitioners after the COVID-19 pandemic. Hoseini R; Hoseini Z BMC Public Health; 2024 Mar; 24(1):798. PubMed ID: 38481173 [TBL] [Abstract][Full Text] [Related]